Good to know 02

Newsletter Good to Know : l'actualité scientifique en cancérologie, vue par Gustave Roussy.

Pediatric Cancer Researchers Receive $1.3 Million to Study Precise Treatment for Neuroblastoma

November 16, 2020

Pediatric Cancer Researchers Receive $1.3 Million to Study Precise Treatment for Neuroblastoma

Grant awarded to CHOP and Gustave Roussy to support phase 3 clinical trial developed by Children’s Oncology Group and International Society of Paediatric Oncology Europe Neuroblastoma Group, representing first-ever collaboration between North American and European neuroblastoma consortia

Pages